Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSCARBIDOPA\FOSLEVODOPA vs FOSINOPRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSCARBIDOPA\FOSLEVODOPA vs FOSINOPRIL: Safety Overview

Metric FOSCARBIDOPA\FOSLEVODOPA FOSINOPRIL
Total FAERS Reports 3,161 461
Deaths Reported 431 36
Death Rate 13.6% 7.8%
Hospitalizations 1,747 219
Average Patient Age 70.4 yrs 66.1 yrs
% Female Patients 42.2% 41.5%
FDA Approval Date N/A Apr 20, 2005
Manufacturer N/A Chartwell RX, LLC
Route N/A ORAL
Marketing Status N/A Discontinued